Treatment refractory chronic spontaneous urticaria may benefit from treatment with dupilumab: A case series of eight patients

S. E.B. Feldborg, S. F. Thomsen, C. Vestergaard^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Research › peer-review

2 Citations (Scopus)

Original language	English
Journal	Journal of the European Academy of Dermatology and Venereology
Volume	38
Issue number	10
Pages (from-to)	e877-e879
ISSN	0926-9959
DOIs	https://doi.org/10.1111/jdv.19976
Publication status	Published - 2024

Access to Document

@article{20cc6c8dab314292b3074432f52c4597,

title = "Treatment refractory chronic spontaneous urticaria may benefit from treatment with dupilumab: A case series of eight patients",

author = "Feldborg, {S. E.B.} and Thomsen, {S. F.} and C. Vestergaard",

year = "2024",

doi = "10.1111/jdv.19976",

language = "English",

volume = "38",

pages = "e877--e879",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "Elsevier",

number = "10",

}

TY - JOUR

T1 - Treatment refractory chronic spontaneous urticaria may benefit from treatment with dupilumab

T2 - A case series of eight patients

AU - Feldborg, S. E.B.

AU - Thomsen, S. F.

AU - Vestergaard, C.

PY - 2024

Y1 - 2024

U2 - 10.1111/jdv.19976

DO - 10.1111/jdv.19976

M3 - Letter

C2 - 38563071

AN - SCOPUS:85189563262

VL - 38

SP - e877-e879

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 10

ER -